BioNTech SE BNTX
NASDAQ BNTX
$89.67 -1.62 (-1.77%)
At close: Oct 22, 2026 · 4:00 PM EDT

BioNTech SE (BNTX) Current Deferred Revenue (2018 - 2026)

Updated

BioNTech SE (BNTX) posted Current Deferred Revenue of $101.82 million for Q2 2026, down 88.6% from $891.64 million a year earlier and down 0.8% from the prior quarter.

Analysis

BioNTech SE (BNTX) Current Deferred Revenue (2018 - 2026) Analysis & Trends

At the end of FY2025, BioNTech SE's Current Deferred Revenue came in at $102.44 million, down 47.6% from FY2024.

  • Annual Current Deferred Revenue shows a five-year compound annual growth rate of 4.5% (FY2020 to FY2025).
  • In prior years, BioNTech SE's Current Deferred Revenue was $195.55 million in FY2024 (-54.4%), $428.76 million in FY2023 (+768.3%), $49.38 million in FY2022 (+379.6%) and $10.3 million in FY2021 (-87.5%).
  • The Q2 2026 figure stands as the lowest quarterly Current Deferred Revenue since Q1 2023.
  • On a year-over-year basis, Current Deferred Revenue has declined in each of the last four quarters, with an average decline of 19.1% over the last eight quarters.
  • The strongest year-over-year quarter for Current Deferred Revenue in the past five years was Q4 2023, with growth of 768.3%; the weakest was Q2 2026, with a decline of 88.6%.
  • According to Business Quant data, Current Deferred Revenue for the three prior quarters was $102.67 million (Q1 2026), $102.44 million (Q4 2025) and $256.02 million (Q3 2025).
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr)
1 Eli Lilly 1,165.22 Bn 1,133.81 Bn 19.71 Bn
2 Johnson & Johnson 646.28 Bn 566.14 Bn 17.30 Bn
3 AbbVie 503.17 Bn 476.28 Bn 12.70 Bn
4 Merck 365.23 Bn 319.60 Bn 12.21 Bn
5 Novartis Ag 302.66 Bn 266.65 Bn 11.24 Bn
6 Astrazeneca 267.39 Bn 241.08 Bn 12.86 Bn
7 Amgen 241.61 Bn 197.01 Bn 7.24 Bn
8 Gilead Sciences 194.67 Bn 168.86 Bn 6.22 Bn
9 Pfizer 172.91 Bn 119.55 Bn 10.94 Bn
10 BioNTech SE 21.69 Bn -24.79 Bn 10.00 Mn
Historic Data

Historic Data

Download Data
DateValue
Jun 30, 2026 100.06 Mn
Mar 31, 2026 100.50 Mn
Dec 31, 2025 103.38 Mn
Sep 30, 2025 256.92 Mn
Jun 30, 2025 923.77 Mn
Mar 31, 2025 197.97 Mn
Dec 31, 2024 190.43 Mn
Sep 30, 2024 420.99 Mn
Jun 30, 2024 378.65 Mn
Mar 31, 2024 409.33 Mn
Dec 31, 2023 441.07 Mn
Sep 30, 2023 283.07 Mn
Jun 30, 2023 328.32 Mn
Mar 31, 2023 49.73 Mn
Dec 31, 2022 51.60 Mn
Sep 30, 2022 52.88 Mn
Jun 30, 2022 58.40 Mn
Mar 31, 2022 74.11 Mn
Dec 31, 2021 10.19 Mn
Sep 30, 2021 12.18 Mn
API Access

BioNTech SE Current Deferred Revenue API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=current-deferred-revenue&ticker=BNTX&period=max&api_key=YOUR_API_KEY